Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03929939 · ClinicalTrials.gov registry record · NA

Neural Control and Cardiac-Vascular Function in Women With PTSD (VA Psychological Assessment)

A NA study, sponsored by North Texas Veterans Healthcare System.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT03929939: Completed NA study, sponsored by North Texas Veterans Healthcare System.

NCT03929939 is a NA study that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03929939, a NA study, has completed, sponsored by North Texas Veterans Healthcare System.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this research is 1) to investigate the role of the sympathetic nervous system and cardiac-vascular function in women with PTSD; and 2) to determine whether lifestyle modifications (exercise training and healthy eating) would be effective in reducing sympathetic activity, improving cardiovascular function, and improving psychiatric and quality of life outcomes in women with PTSD. It is hypothesized that (1) women with PTSD will have over-activation of the sympathetic nervous system and impaired cardiac-vascular function compared with women who are trauma free, and (2) lifestyle modifications can reduce sympathetic activity, improve cardiac-vascular function, and improve psychiatric symptoms and quality of life in women with PTSD.

Primary Outcome

Muscle sympathetic nerve activity will be measured using microneurography at the peroneal nerve.

Interventions

  • BEHAVIORAL Exercise training and healthy eating (overseen by IEEM research team)

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2017-03-27
Est. Completion 2018-01-09
Phase NA

What the finished NCT03929939 record still lists

NCT03929939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise training and healthy eating (overseen by IEEM research team) is the first listed.

NCT03929939 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03929939 about?

NCT03929939 is a clinical study titled "Neural Control and Cardiac-Vascular Function in Women With PTSD (VA Psychological Assessment)". The purpose of this research is 1) to investigate the role of the sympathetic nervous system and cardiac-vascular function in women with PTSD; and 2) to determine whether lifestyle modifications (exercise training and healthy eating) would be effective in reducing sympathetic activity, improving car...

What is the current status of trial NCT03929939?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-03-27. Estimated completion is 2018-01-09.

What interventions are being tested in trial NCT03929939?

The interventions under investigation include: Exercise training and healthy eating (overseen by IEEM research team) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03929939?

This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03929939's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03929939, the US trial registry maintained by the National Library of Medicine. NCT03929939 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.